Vanadis Diagnostics AB has been sold to PerkinElmer, Inc. Based in Sweden, Vanadis is developing a novel solution for non-invasive prenatal testing (NIPT) based on digital analysis of cell-free DNA.

Hannes Snellman acted as counsel to the shareholders of Vanadis Diagnostics. Our team included: Sara Mindus, Bruce McGinn and Taymaz Afsari.